Endpoint Assessment in Rabbit Models of Invasive Pulmonary Aspergillosis and Mucormycosis.

about

Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis.Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

P2860

Q40140001-6708ED28-FC7C-4343-B49E-1DA002E430EE Q55511181-78292D51-9F34-4DED-A655-5DC8FAE1126B

P2860

Endpoint Assessment in Rabbit Models of Invasive Pulmonary Aspergillosis and Mucormycosis.

Item

http://www.wikidata.org/entity/Q40183751

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Endpoint Assessment in Rabbit ...... spergillosis and Mucormycosis.

@en

type

Item

label

Endpoint Assessment in Rabbit ...... spergillosis and Mucormycosis.

@en

prefLabel

Endpoint Assessment in Rabbit ...... spergillosis and Mucormycosis.

@en

P1476

Endpoint Assessment in Rabbit ...... spergillosis and Mucormycosis.

@en

P2093

Ruta Petraitiene

http://www.w3.org/2001/XMLSchema#string

Thomas J Walsh

http://www.w3.org/2001/XMLSchema#string

Vidmantas Petraitis

http://www.w3.org/2001/XMLSchema#string

P2860

Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia

Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits.

Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbits.

Dose-dependent pharmacokinetics of amphotericin B lipid complex in rabbits.

Compartmental pharmacokinetics of the antifungal echinocandin caspofungin (MK-0991) in rabbits.

Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.

The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy.

Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis.

Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.

Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations.

P304

259-277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-1-4939-7104-6_18

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1625

http://www.w3.org/2001/XMLSchema#string

P50

William Hope

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28584996

http://www.w3.org/2001/XMLSchema#string

P921

aspergillosis

Endpoint Assessment in Rabbit Models of Invasive Pulmonary Aspergillosis and Mucormycosis.

about

P2860

P2860

Endpoint Assessment in Rabbit Models of Invasive Pulmonary Aspergillosis and Mucormycosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921